Suppr超能文献

经皮冠状动脉介入治疗(PCI)在慢性完全闭塞(CTO)中的适应证:我们是否已经做出了决定,还是在 EURO-CTO 之后继续探索?

Indications for Percutaneous Coronary Intervention (PCI) in Chronic Total Occlusion (CTO): Have We Reached a DECISION or Do We Continue to EXPLORE After EURO-CTO?

机构信息

Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.

Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia.

出版信息

Heart Lung Circ. 2019 Oct;28(10):1484-1489. doi: 10.1016/j.hlc.2019.03.014. Epub 2019 Apr 12.

Abstract

A coronary chronic total occlusion (CTO) is a common finding during coronary angiography and is associated with increased mortality and poorer cardiovascular prognosis. Technological developments in percutaneous strategies for revascularisation have resulted in increased interest in this area. However, until recently, there has been a paucity of robust scientific randomised data comparing the efficacy of medical management with percutaneous strategies. Both observational data, and to a lesser extent, randomised data, suggest that CTO percutaneous coronary intervention (PCI) should be considered in symptomatic patients. However, in the absence of any randomised data, CTO PCI should not be performed for prognostic benefit. Ongoing trials are needed to confirm these findings as well as to identify the optimal timing and strategy of such interventions.

摘要

冠状动脉慢性完全闭塞(CTO)是冠状动脉造影中的常见发现,与死亡率增加和心血管预后不良相关。经皮血运重建策略的技术发展导致人们对此领域的兴趣增加。然而,直到最近,在比较药物治疗与经皮策略的疗效方面,仍然缺乏强有力的科学随机数据。观察性数据,以及在较小程度上的随机数据,表明在有症状的患者中应考虑 CTO 经皮冠状动脉介入治疗(PCI)。但是,由于缺乏任何随机数据,不应出于预后获益的目的而进行 CTO PCI。需要进行正在进行的试验来证实这些发现,并确定此类干预的最佳时机和策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验